Predicting long-term clinical stability in amyloid-positive subjects by FDG-PET.
Aged
Aged, 80 and over
Alzheimer Disease
/ diagnostic imaging
Amyloid beta-Peptides
/ metabolism
Biomarkers
/ metabolism
Brain
Clinical Trials as Topic
Cognitive Dysfunction
/ diagnostic imaging
Dementia
/ diagnosis
Disease Progression
Female
Fluorodeoxyglucose F18
/ metabolism
Healthy Volunteers
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Positron-Emission Tomography
/ methods
Journal
Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
15
12
2018
revised:
13
03
2019
accepted:
01
04
2019
entrez:
19
6
2019
pubmed:
19
6
2019
medline:
19
6
2019
Statut:
epublish
Résumé
Imaging biomarkers can be used to screen participants for Alzheimer's disease clinical trials. To test the predictive values in clinical progression of neuropathology change (amyloid-PET) or brain metabolism as neurodegeneration biomarker ([18F]FDG-PET), we evaluated data from
Identifiants
pubmed: 31211176
doi: 10.1002/acn3.782
pii: ACN3782
pmc: PMC6562030
doi:
Substances chimiques
Amyloid beta-Peptides
0
Biomarkers
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Langues
eng
Pagination
1113-1120Subventions
Organisme : NIA NIH HHS
ID : U01 AG024904
Pays : United States
Déclaration de conflit d'intérêts
Nothing to report.
Références
Alzheimers Dement. 2010 May;6(3):221-9
pubmed: 20451870
Neurobiol Aging. 2010 Aug;31(8):1429-42
pubmed: 20541286
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
PLoS One. 2012;7(10):e47739
pubmed: 23082203
Neurology. 2013 Mar 12;80(11):1048-56
pubmed: 23390179
PLoS One. 2013 Jul 04;8(7):e68910
pubmed: 23861951
Neuroimage Clin. 2014 Oct 24;6:445-54
pubmed: 25389519
Neurology. 2015 Feb 3;84(5):508-15
pubmed: 25568301
Neuroimage Clin. 2014 Dec 05;7:187-94
pubmed: 25610780
Alzheimers Dement. 2015 Oct;11(10):1191-201
pubmed: 25646957
JAMA. 2015 May 19;313(19):1924-38
pubmed: 25988462
JAMA. 2015 May 19;313(19):1939-49
pubmed: 25988463
Alzheimers Dement. 2015 Jul;11(7):757-71
pubmed: 26194311
Neurobiol Aging. 2016 Jan;37:26-37
pubmed: 26545631
Alzheimer Dis Assoc Disord. 2016 Jan-Mar;30(1):1-7
pubmed: 26885819
J Neuropathol Exp Neurol. 2016 Apr;75(4):316-25
pubmed: 26979082
Neurology. 2016 Sep 20;87(12):1235-41
pubmed: 27558378
JAMA Neurol. 2017 May 1;74(5):540-548
pubmed: 28288263
Alzheimers Dement. 2017 Apr;13(4):e1-e85
pubmed: 28342697
Clin Transl Sci. 2018 Mar;11(2):147-152
pubmed: 28767185
Alzheimers Dement (N Y). 2017 Sep 21;3(4):513-523
pubmed: 29124109
Lancet Neurol. 2018 Apr;17(4):335-346
pubmed: 29500152
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
Alzheimers Dement. 2018 Aug;14(8):981-988
pubmed: 29802030